Skip to content
  • Debatforum
  • Seneste
  • Populære
  • Bruger
Temaer
  • Light
  • Dark

Kollaps
FORSIDEN
Log ind Opret konto

Genmab — November 2015

Planlagt Fastgjort Låst Flyttet Genmab
2.4k Indlæg 1 Posters 0 Visninger
  • Ældste til nyeste
  • Nyeste til ældste
  • Most Votes
Svar
  • Svar som emne
Login for at svare
Denne tråd er blevet slettet. Kun brugere med emne behandlings privilegier kan se den.
  • J Offline
    J Offline
    jkj
    wrote on sidst redigeret af
    #1223

    tror mere på mcjean tal, efter at have regnet på det.

    1 Reply Last reply
    0
    • J Offline
      J Offline
      jkj
      wrote on sidst redigeret af
      #1224

      rettelse 8 ugentlige i 2 måneder, inden der afgøres om behandling stoppes, eller forsættes i længere intevaller

      1 Reply Last reply
      0
      • BulderB Offline
        BulderB Offline
        Bulder
        wrote on sidst redigeret af
        #1225

        Hver behandlingscyklus på 28 dage indebærer 4 infusioner https://www.clinicaltrials.gov/ct2/show/study/NCT02477891?term=daratumumab&rank=16&show_locs=Y#locn Hvis vi antager jkj's pris pr infusion og 12000 patienter bliver det 280 mio $ om måneden.

        1 Reply Last reply
        0
        • J Offline
          J Offline
          jkj
          wrote on sidst redigeret af
          #1226

          prisen er oplust af j&j her til aften

          1 Reply Last reply
          0
          • J Offline
            J Offline
            jkj
            wrote on sidst redigeret af
            #1227

            oplyst

            1 Reply Last reply
            0
            • J Offline
              J Offline
              jkj
              wrote on sidst redigeret af
              #1228

              http://www.newsmax.com/Health/Health-News/multiple-myeloma-drug-cancer-approved/2015/11/16/id/702389/

              1 Reply Last reply
              0
              • J Offline
                J Offline
                jkj
                wrote on sidst redigeret af
                #1229

                Link Preview Image
                DARZALEX® (daratumumab) Approved by U.S. FDA: First Human Anti-CD38 Monoclonal Antibody Available for the Treatment of Multiple Myeloma

                First-in-class immunotherapy approved for multiple myeloma patients who have received three or more prior lines of therapy, including a proteasome inhibitor (PI) and an immunomodulatory agent or who are double refractory to a PI and immunomodulatory agent

                favicon

                Multivu (www.multivu.com)

                1 Reply Last reply
                0
                • BulderB Offline
                  BulderB Offline
                  Bulder
                  wrote on sidst redigeret af
                  #1230

                  Hvis de 280 mio $ om måneden holder giver det med royalty 16% og en forsigtig p/e=20 en kurs på 1225 alene på Darzalex

                  1 Reply Last reply
                  0
                  • BulderB Offline
                    BulderB Offline
                    Bulder
                    wrote on sidst redigeret af
                    #1231

                    ... og kun USA

                    1 Reply Last reply
                    0
                    • J Offline
                      J Offline
                      jkj
                      wrote on sidst redigeret af
                      #1232

                      self- vil nogle ikke vise respons på behandling, og vil hurtigt falde fra, men hvorfor skulle alle i målgruppen ikke have chancen, og hurtigt da de intet alternativ har.

                      1 Reply Last reply
                      0
                      • J Offline
                        J Offline
                        jkj
                        wrote on sidst redigeret af
                        #1233

                        pt.

                        1 Reply Last reply
                        0
                        • D Offline
                          D Offline
                          dohk
                          wrote on sidst redigeret af
                          #1234

                          så er den første patient også blevet behandlet med subcutant dara.http://www.news-medical.net/news/20151105/Janssen-doses-first-patient-in-daratumumab-clinical-trial-using-Halozymes-ENHANZE-technology.aspx

                          1 Reply Last reply
                          0
                          • D Offline
                            D Offline
                            dohk
                            wrote on sidst redigeret af
                            #1235

                            Men det drukner nok lidt i kursudviklingen i morgen.

                            1 Reply Last reply
                            0
                            • BudweisB Offline
                              BudweisB Offline
                              Budweis
                              wrote on sidst redigeret af
                              #1236

                              dohk - det er en gammel nyhed. Den er fra 5. nov.

                              1 Reply Last reply
                              0
                              • BudweisB Offline
                                BudweisB Offline
                                Budweis
                                wrote on sidst redigeret af
                                #1237

                                Deutche er klar med første opjustering. "Completely de-risking daratumumab over the next 12 months would represent potential upside to our DCF-derived price target to DKK1000.
                                "

                                1 Reply Last reply
                                0
                                • Smadsen128S Offline
                                  Smadsen128S Offline
                                  Smadsen128
                                  wrote on sidst redigeret af
                                  #1238

                                  Lige de rigtige dag for affyring af Genmab raketten....både USA og Asien med pæne stigninger....glæder mig søm et lille barn til kl ni....god fornøjelse

                                  1 Reply Last reply
                                  0
                                  • Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktørH Offline
                                    Helge_LarsenPI-redaktør
                                    wrote on sidst redigeret af
                                    #1239

                                    God morgen. 🙂

                                    1 Reply Last reply
                                    0
                                    • J Offline
                                      J Offline
                                      JKY_VH
                                      wrote on sidst redigeret af
                                      #1240

                                      God morGEN til en forhåbentlig spændende dag på børsen og på grønsværen.

                                      1 Reply Last reply
                                      0
                                      • R Offline
                                        R Offline
                                        Repsac
                                        wrote on sidst redigeret af
                                        #1241

                                        Daratumumab is given once a week for the first two months of treatment, then the infusions wind down to once monthly in the second 6 months of the year, says a spokesperson for J&J. For the first full year--with a total of 23 doses given at a cost of $5,850 per infusion--the average monthly wholesale acquisition cost is $11,212, says J&J, or $135,550 for the first year. In year two, and any year thereafter, patients receive a total of 13 doses, for a monthly wholesale cost of $6,337, or $76,044

                                        1 Reply Last reply
                                        0
                                        • Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktørH Offline
                                          Helge_LarsenPI-redaktør
                                          wrote on sidst redigeret af
                                          #1242

                                          Sydbank: http://www.proinvestor.com/index.php?p=debat_1&postid=73629

                                          1 Reply Last reply
                                          0

                                          Hello! It looks like you're interested in this conversation, but you don't have an account yet.

                                          Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.

                                          With your input, this post could be even better 💗

                                          Tilmeld Log ind

                                          • Log ind

                                          • Har du ikke en konto? Tilmeld

                                          • Login or register to search.
                                          • First post
                                            Last post
                                          0
                                          • Debatforum
                                          • Seneste
                                          • Populære
                                          • Bruger